|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
CA2202397C
(en)
|
1994-10-17 |
2002-07-16 |
Peter W. Stacpoole |
Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
|
|
US5496545A
(en)
|
1993-08-11 |
1996-03-05 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
|
US5667775A
(en)
|
1993-08-11 |
1997-09-16 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
|
US5648355A
(en)
|
1994-02-09 |
1997-07-15 |
Kos Pharmaceutical, Inc. |
Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
|
|
TW474813B
(en)
|
1994-06-10 |
2002-02-01 |
Geltex Pharma Inc |
Alkylated composition for removing bile salts from a patient
|
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
US5753706A
(en)
|
1996-12-16 |
1998-05-19 |
Hsu; Chen Hsing |
Methods for treating renal failure
|
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
|
US6726905B1
(en)
|
1997-11-05 |
2004-04-27 |
Genzyme Corporation |
Poly (diallylamines)-based phosphate binders
|
|
WO1999040990A1
(en)
|
1998-02-17 |
1999-08-19 |
University Of Maryland |
Anion binding polymers and the use thereof
|
|
US6485703B1
(en)
|
1998-07-31 |
2002-11-26 |
The Texas A&M University System |
Compositions and methods for analyte detection
|
|
US6271264B1
(en)
|
1998-12-01 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
|
|
US6733780B1
(en)
|
1999-10-19 |
2004-05-11 |
Genzyme Corporation |
Direct compression polymer tablet core
|
|
GB9927088D0
(en)
|
1999-11-17 |
2000-01-12 |
Secr Defence |
Use of poly(diallylamine) polymers
|
|
AU2001241076A1
(en)
|
2000-03-09 |
2001-09-17 |
Hisamitsu Pharmaceutical Co. Inc. |
Crosslinked anion-exchange resin or salt thereof
|
|
WO2001066607A1
(en)
|
2000-03-09 |
2001-09-13 |
Hisamitsu Pharmaceutical Co., Inc. |
Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
|
|
US20030091530A1
(en)
|
2000-03-13 |
2003-05-15 |
Takeshi Goto |
Preventives and/or remedies for hyperphosphatemia
|
|
JP2002028737A
(ja)
|
2000-07-07 |
2002-01-29 |
Fujitsu Ltd |
プレス打ち抜き加工方法及びプレス打ち抜き加工装置
|
|
AT409630B
(de)
*
|
2000-12-13 |
2002-09-25 |
Dsm Fine Chem Austria Gmbh |
Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
|
|
WO2002085381A1
(en)
|
2001-04-18 |
2002-10-31 |
Genzyme Corporation |
Method for treating gout and binding uric acid
|
|
DE60212819T2
(de)
|
2001-04-18 |
2006-11-23 |
Genzyme Corp., Cambridge |
Salzformarme polyallylamine
|
|
CA2478599A1
(en)
|
2002-03-11 |
2003-09-18 |
Novartis Ag |
Salts of nateglinide
|
|
WO2004069866A1
(en)
|
2003-02-10 |
2004-08-19 |
Autogen Research Pty Ltd |
Therapeutic molecules
|
|
TWI335218B
(en)
|
2003-02-19 |
2011-01-01 |
Panion & Bf Biotech Inc |
Ferric organic compounds, uses thereof and methods of making same
|
|
US7608674B2
(en)
|
2003-11-03 |
2009-10-27 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
|
US7459502B2
(en)
|
2003-11-03 |
2008-12-02 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising crosslinked polyamine polymers
|
|
US7767768B2
(en)
|
2003-11-03 |
2010-08-03 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
|
US7385012B2
(en)
|
2003-11-03 |
2008-06-10 |
Ilypsa, Inc. |
Polyamine polymers
|
|
US7335795B2
(en)
|
2004-03-22 |
2008-02-26 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
|
US7449605B2
(en)
|
2003-11-03 |
2008-11-11 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
|
CA2551528A1
(en)
|
2003-12-31 |
2005-07-21 |
Genzyme Corporation |
Enteric coated aliphatic amine polymer bile acid sequestrants
|
|
KR20060128972A
(ko)
|
2004-01-29 |
2006-12-14 |
각고호우징 게이오기주크 |
적혈구 기능 수식 물질
|
|
BRPI0509365B8
(pt)
|
2004-03-30 |
2021-05-25 |
Ilypsa Inc |
composição farmacêutica, kit farmacêutico, e, uso da referida composição
|
|
US7429394B2
(en)
|
2004-03-30 |
2008-09-30 |
Relypsa, Inc. |
Ion binding compositions
|
|
US7556799B2
(en)
|
2004-03-30 |
2009-07-07 |
Relypsa, Inc. |
Ion binding polymers and uses thereof
|
|
US8192758B2
(en)
|
2004-03-30 |
2012-06-05 |
Relypsa, Inc. |
Ion binding compositions
|
|
US8282960B2
(en)
|
2004-03-30 |
2012-10-09 |
Relypsa, Inc. |
Ion binding compositions
|
|
US7854924B2
(en)
|
2004-03-30 |
2010-12-21 |
Relypsa, Inc. |
Methods and compositions for treatment of ion imbalances
|
|
US8399025B2
(en)
|
2004-06-04 |
2013-03-19 |
Board Of Regents, The University Of Texas System |
Polyamine modified particles
|
|
US8501676B2
(en)
|
2004-07-19 |
2013-08-06 |
N.V. Nutricia |
Preparation for use of aspartate for regulating glucose levels in blood
|
|
DE102004035808A1
(de)
|
2004-07-21 |
2006-03-16 |
Kasch, Helmut, Dr. |
Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
|
|
US8569277B2
(en)
|
2004-08-11 |
2013-10-29 |
Palo Alto Investors |
Methods of treating a subject for a condition
|
|
US20080214440A1
(en)
|
2004-10-08 |
2008-09-04 |
Forbes Medi-Tech (Research), Inc. |
Vasoactive intestinal polypeptide compositions
|
|
US20070293429A1
(en)
|
2004-10-08 |
2007-12-20 |
Therapei Pharmaceuticals, Inc. |
Vasoactive Intestinal Polypeptide Compositions
|
|
US7985418B2
(en)
|
2004-11-01 |
2011-07-26 |
Genzyme Corporation |
Aliphatic amine polymer salts for tableting
|
|
ITME20040015A1
(it)
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
|
US20080200533A1
(en)
|
2005-07-04 |
2008-08-21 |
Ramu Krishnan |
Drug or Pharmaceutical Compounds and a Preparation Thereof
|
|
CA2619591C
(en)
|
2005-08-18 |
2020-03-24 |
Globoasia, Llc |
Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
|
|
US8986669B2
(en)
|
2005-09-02 |
2015-03-24 |
Genzyme Corporation |
Method for removing phosphate and polymer used therefore
|
|
WO2007038801A2
(en)
|
2005-09-30 |
2007-04-05 |
Ilypsa, Inc. |
Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
|
|
BRPI0616603A2
(pt)
|
2005-09-30 |
2012-12-25 |
Ilypsa Inc |
mÉtodo para preparar um compàsito de nécleo-envoltàrio, e para a manufatura de um medicamento, composiÇço farmacÊutica, e, uso da mesma
|
|
WO2007041569A1
(en)
|
2005-09-30 |
2007-04-12 |
Ilypsa, Inc. |
Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
|
|
EP1945196A2
(en)
|
2005-11-08 |
2008-07-23 |
Genzyme Corporation |
Magnesium-containing polymers for hyperphosphatemia
|
|
WO2007055044A1
(ja)
|
2005-11-08 |
2007-05-18 |
Ajinomoto Co., Inc. |
麻酔覚醒促進剤
|
|
ITMI20052461A1
(it)
|
2005-12-22 |
2007-06-23 |
Univ Degli Studi Milano |
Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
|
|
RU2008136081A
(ru)
|
2006-02-14 |
2010-03-20 |
Тева Фармасьютикл Индастриес Лтд. (Il) |
Фармацевтические составы с алифатическими аминными полимерами и способы их производства
|
|
EP2016114A2
(en)
|
2006-05-05 |
2009-01-21 |
Genzyme Corporation |
Amine condensation polymers as phosphate sequestrants
|
|
EP2043627A2
(en)
|
2006-07-05 |
2009-04-08 |
Genzyme Corporation |
Iron(ii)-containing treatments for hyperphosphatemia
|
|
US20100124542A1
(en)
|
2006-07-18 |
2010-05-20 |
Genzyme Corporation |
Amine dendrimers
|
|
WO2008016729A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
CA2749074A1
(en)
|
2006-09-01 |
2008-05-29 |
Usv Limited |
Process for the preparation of sevelamer hydrochloride and formulation thereof
|
|
EP2068819A4
(en)
|
2006-09-01 |
2011-04-20 |
Genzyme Corp |
Dendrimer COMPOSITIONS
|
|
US7964182B2
(en)
|
2006-09-01 |
2011-06-21 |
USV, Ltd |
Pharmaceutical compositions comprising phosphate-binding polymer
|
|
US7868045B2
(en)
|
2006-09-06 |
2011-01-11 |
Sucampo Ag |
Method for promoting gastrointestinal bicarbonate secretion
|
|
EP2066293A2
(en)
|
2006-09-29 |
2009-06-10 |
Genzyme Corporation |
Amide dendrimer compositions
|
|
US8163799B2
(en)
|
2006-12-14 |
2012-04-24 |
Genzyme Corporation |
Amido-amine polymer compositions
|
|
JP2010519298A
(ja)
|
2007-02-23 |
2010-06-03 |
ゲンズイメ コーポレーション |
アミンポリマー組成物
|
|
US20080207766A1
(en)
|
2007-02-27 |
2008-08-28 |
Agi Therapeutics Research Ltd. |
Methods and compositions for treating at least one upper gastrointestinal symptom
|
|
JP2010520285A
(ja)
|
2007-03-08 |
2010-06-10 |
ゲンズイメ コーポレーション |
スルホンポリマー組成物
|
|
TWI445540B
(zh)
|
2007-04-20 |
2014-07-21 |
Ajinomoto Kk |
抗低體溫組成物
|
|
US20100166696A1
(en)
|
2007-04-27 |
2010-07-01 |
Dhal Pradeep K |
Amido-amine dendrimer compositions
|
|
US8273384B2
(en)
|
2007-07-02 |
2012-09-25 |
Stephen Ray Wurzberger |
Process for the preparation of a non-corrosive base solution and methods of using same
|
|
KR20100045965A
(ko)
|
2007-07-11 |
2010-05-04 |
도레이 카부시키가이샤 |
가교 폴리알릴아민 또는 그 산부가염 및 그 의약 용도
|
|
EP2016947A1
(en)
|
2007-07-17 |
2009-01-21 |
Chemo Ibérica, S.A. |
Novel one step process for preparing cross-linked poly(allylamine) polymers
|
|
WO2009023544A2
(en)
|
2007-08-10 |
2009-02-19 |
Ilypsa, Inc. |
Dosage unit anion-exchange polymer pharmaceutical compositions
|
|
US20090156647A1
(en)
|
2007-12-12 |
2009-06-18 |
Iovate T. & P. Inc. |
Method for maintaining physiological pH levels during intensive physical exercise
|
|
PA8807201A1
(es)
|
2007-12-14 |
2009-07-23 |
Genzyme Corp |
Composiciones farmaceuticas
|
|
EP2217215A1
(en)
|
2007-12-14 |
2010-08-18 |
Genzyme Corporation |
Coated pharmaceutical compositions
|
|
WO2009097127A1
(en)
|
2008-01-31 |
2009-08-06 |
Genzyme Corporation |
Pharmaceutical compositions
|
|
EP2282729A1
(en)
|
2008-03-11 |
2011-02-16 |
Livionex Inc. |
Methods and compositions for treating inflammation and inflammation-related pathologies
|
|
AU2009235024A1
(en)
|
2008-04-08 |
2009-10-15 |
Usv Limited |
Process for preparation of amine polymer salt
|
|
WO2009154747A1
(en)
|
2008-06-20 |
2009-12-23 |
Genzyme Corporation |
Pharmaceutical compositions
|
|
DE102008030046A1
(de)
|
2008-06-25 |
2009-12-31 |
Ratiopharm Gmbh |
Kompaktiertes Polyallylamin-Polymer
|
|
US20100008988A1
(en)
|
2008-07-14 |
2010-01-14 |
Glenmark Generics, Ltd. |
Tablet compositions of amine polymers
|
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
|
US8337824B2
(en)
|
2008-08-22 |
2012-12-25 |
Relypsa, Inc. |
Linear polyol stabilized polyfluoroacrylate compositions
|
|
WO2010022381A1
(en)
|
2008-08-22 |
2010-02-25 |
Relypsa, Inc. |
Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
|
|
KR20110066952A
(ko)
|
2008-09-25 |
2011-06-17 |
비브 나노, 인코포레이티드 |
중합체 나노입자 및 활성 성분의 제형을 제조하는 방법
|
|
US20110268666A1
(en)
|
2008-09-29 |
2011-11-03 |
Yissum Research Development Company of the Research University of Jerusalem, Ltd. |
Novel gastroretentive delivery system
|
|
WO2010059384A1
(en)
|
2008-10-30 |
2010-05-27 |
Janssen Pharmaceutica Nv |
Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
|
|
US20100166861A1
(en)
|
2008-12-29 |
2010-07-01 |
Kelly Noel Lynch |
Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
|
|
EP2389168A2
(en)
*
|
2009-01-22 |
2011-11-30 |
USV Limited |
Pharmaceutical compositions comprising phosphate-binding polymer
|
|
WO2011059609A2
(en)
|
2009-10-13 |
2011-05-19 |
The Regents Of The University Of Michigan |
Dendrimer compositions and methods of synthesis
|
|
EP2490675B1
(en)
|
2009-10-22 |
2019-01-23 |
Synthon B.V. |
Pharmaceutical compositions of sevelamer
|
|
JP5984675B2
(ja)
|
2009-12-07 |
2016-09-06 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
胃腸障害の療法
|
|
CN105017481B
(zh)
|
2010-02-24 |
2018-10-02 |
瑞立普萨公司 |
用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
|
|
CN102858347B
(zh)
|
2010-02-24 |
2016-11-02 |
瑞立普萨公司 |
用作胆汁酸螯合剂的聚咪唑
|
|
IT1406068B1
(it)
*
|
2010-07-22 |
2014-02-06 |
Medestea Int Spa |
Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
|
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
KR101238210B1
(ko)
|
2011-06-30 |
2013-03-04 |
엘지전자 주식회사 |
이동 단말기
|
|
US20130137772A1
(en)
|
2011-11-29 |
2013-05-30 |
Raymond J. Bergeron |
Hydroxypolyamine salts
|
|
US20130345303A1
(en)
|
2012-06-21 |
2013-12-26 |
Keryx Biopharmaceuticals, Inc. |
Use of ferric citrate in the treatment of chronic kidney disease patients
|
|
KR20210005314A
(ko)
|
2012-10-08 |
2021-01-13 |
리립사, 인크. |
고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제
|
|
EP3003327B1
(en)
|
2013-06-05 |
2017-08-09 |
Tricida Inc. |
Proton-binding polymers for oral administration
|
|
EP3747432A1
(en)
|
2013-11-04 |
2020-12-09 |
Keryx Biopharmaceuticals, Inc. |
Ferric citrate for reducing cardiac failure in chronic kidney disease patients
|
|
RS61409B1
(sr)
|
2014-12-10 |
2021-03-31 |
Tricida Inc |
Polimeri koji vezuju protone za oralnu primenu opis
|
|
CN109414453B
(zh)
|
2016-05-06 |
2023-02-17 |
特里赛达公司 |
用于治疗酸碱失衡的组合物
|
|
US10934380B1
(en)
|
2017-09-25 |
2021-03-02 |
Tricida, Inc. |
Crosslinked poly(allylamine) polymer pharmaceutical compositions
|
|
CA3080651A1
(en)
|
2017-11-03 |
2019-05-09 |
Tricida, Inc. |
Compositions for and method of treating acid-base disorders
|
|
AU2018360868B2
(en)
|
2017-11-03 |
2025-01-02 |
Tricida, Inc. |
Method of treating acid-base disorders
|
|
CA3102765A1
(en)
|
2018-06-04 |
2019-12-12 |
Tricida, Inc. |
Method of treating acid-base disorders
|
|
WO2019236124A1
(en)
|
2018-06-04 |
2019-12-12 |
Tricida, Inc. |
Method of treating acid-base disorders
|
|
WO2019236639A1
(en)
|
2018-06-04 |
2019-12-12 |
Tricida, Inc. |
Method of treating acid-base disorders
|
|
US20200306209A1
(en)
|
2019-03-27 |
2020-10-01 |
Tricida, Inc. |
Method of treating acid-base disorders
|